CN1031862C - 药物组合物及其制备方法 - Google Patents

药物组合物及其制备方法 Download PDF

Info

Publication number
CN1031862C
CN1031862C CN88108149A CN88108149A CN1031862C CN 1031862 C CN1031862 C CN 1031862C CN 88108149 A CN88108149 A CN 88108149A CN 88108149 A CN88108149 A CN 88108149A CN 1031862 C CN1031862 C CN 1031862C
Authority
CN
China
Prior art keywords
cellulose
weight
tetracycline
thickener
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN88108149A
Other languages
English (en)
Chinese (zh)
Other versions
CN1042832A (zh
Inventor
皮特·约翰尼斯·阿克布莫
罗伯特·德·科克
伯纳德斯·巴塞洛米厄斯·玛丽亚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Europe BV
Original Assignee
Yamanouchi Europe Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europe Co ltd filed Critical Yamanouchi Europe Co ltd
Publication of CN1042832A publication Critical patent/CN1042832A/zh
Application granted granted Critical
Publication of CN1031862C publication Critical patent/CN1031862C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN88108149A 1987-11-30 1988-11-29 药物组合物及其制备方法 Expired - Lifetime CN1031862C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP87202370 1987-11-30
EP87202370.0 1987-11-30

Publications (2)

Publication Number Publication Date
CN1042832A CN1042832A (zh) 1990-06-13
CN1031862C true CN1031862C (zh) 1996-05-29

Family

ID=8197711

Family Applications (1)

Application Number Title Priority Date Filing Date
CN88108149A Expired - Lifetime CN1031862C (zh) 1987-11-30 1988-11-29 药物组合物及其制备方法

Country Status (17)

Country Link
EP (1) EP0319074B1 (enExample)
JP (1) JPH02211A (enExample)
KR (1) KR890007745A (enExample)
CN (1) CN1031862C (enExample)
AT (1) ATE72118T1 (enExample)
AU (1) AU611740B2 (enExample)
CA (1) CA1334933C (enExample)
DE (1) DE3868245D1 (enExample)
DK (1) DK175526B1 (enExample)
ES (1) ES2047540T3 (enExample)
FI (1) FI89455C (enExample)
GR (1) GR3003872T3 (enExample)
IE (1) IE65552B1 (enExample)
IL (1) IL88529A (enExample)
NO (1) NO176347C (enExample)
NZ (1) NZ227117A (enExample)
PT (1) PT89105B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
ATE349203T1 (de) * 1998-06-11 2007-01-15 Pharmacia & Upjohn Co Llc Delavirdin tablettenformulierung
US7237118B2 (en) * 2002-12-05 2007-06-26 Microsoft Corporation Methods and systems for authentication of a user for sub-locations of a network location
KR100764206B1 (ko) * 2003-07-21 2007-10-05 주식회사 만도 전동식 파워 스티어링 시스템에서의 디씨 모터 각속도추정방법
US7943585B2 (en) * 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
JP2007134586A (ja) * 2005-11-11 2007-05-31 Hitachi High-Technologies Corp 真空排気装置
TWI482641B (zh) * 2006-12-07 2015-05-01 Daiichi Sankyo Co Ltd 含有低取代度羥丙基纖維素之醫藥組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058565B (en) * 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
JPS6097919A (ja) * 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) * 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.

Also Published As

Publication number Publication date
KR890007745A (ko) 1989-07-05
AU611740B2 (en) 1991-06-20
EP0319074B1 (en) 1992-01-29
IE883560L (en) 1989-05-30
IE65552B1 (en) 1995-11-01
PT89105B (pt) 1994-09-30
AU2640688A (en) 1989-06-01
FI89455C (fi) 1993-10-11
DK175526B1 (da) 2004-11-22
IL88529A (en) 1993-01-31
GR3003872T3 (enExample) 1993-03-16
NZ227117A (en) 1991-08-27
NO885318D0 (no) 1988-11-29
NO176347B (no) 1994-12-12
JPH02211A (ja) 1990-01-05
FI885506L (fi) 1989-05-31
CN1042832A (zh) 1990-06-13
DK664488D0 (da) 1988-11-29
EP0319074A1 (en) 1989-06-07
PT89105A (pt) 1989-11-30
FI885506A0 (fi) 1988-11-28
ATE72118T1 (de) 1992-02-15
NO176347C (no) 1995-03-22
ES2047540T3 (es) 1994-03-01
DE3868245D1 (de) 1992-03-12
FI89455B (fi) 1993-06-30
CA1334933C (en) 1995-03-28
NO885318L (no) 1989-05-31
DK664488A (da) 1989-05-31

Similar Documents

Publication Publication Date Title
US5211958A (en) Pharmaceutical composition and process for its preparation
EP0330284B1 (en) Process for the preparation of a pharmaceutical granulate
KR101590115B1 (ko) 약학 조성물
JP5784502B2 (ja) ウリプリスタール酢酸エステル錠
CN100352432C (zh) 含有那格列奈的制剂
IE880584L (en) Pharmaceutical tablet, pharmaceutical granulate and process¹for their preparation
JPH0122245B2 (enExample)
EP0301006B1 (en) Methylprednisolone/sodium carboxymethyl starch tablet composition
JPH0669965B2 (ja) 固体持続放出医薬製剤
US20030104059A1 (en) Controlled release tablets of metformin
CA1334933C (en) Pharmaceutical composition and process for its preparation
JP2010001242A (ja) レバミピド固形製剤及びその製造方法
KR100267525B1 (ko) 시타라빈 옥포스페이트 경질 캡슐제
JP4370050B2 (ja) クラリスロマイシン錠剤およびその製造法
EP2671569B1 (en) Stable pharmaceutical compositions with fast onset
JPH09100229A (ja) ロキソプロフェン・ナトリウム含有固形製剤
JP4249847B2 (ja) ビタミンｋを含有する口腔内崩壊型錠剤
JPH05221853A (ja) 崩壊性良好な生薬類含有造粒物
JPH115739A (ja) ベザフィブラート含有持続性製剤およびその製造方法
JPS615027A (ja) 徐放性固形製剤
CN115813873A (zh) 一种替米沙坦片及其制备方法
JP2008214325A (ja) 固形製剤
CN101244052A (zh) 一种含有降血脂成分的口服固体制剂
CN1778300A (zh) 一种罗通定口腔崩解片及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: Holland Leiderdorp

Applicant after: Buluokadesi drugs Co. Ltd.

Address before: Delft

Applicant before: Gist-Brocades S. A.

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: GIST-BROCADES S. A. TO: BURO CADIZ PHARM PUR GMBH

C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Applicant after: Yamamouchi Eurpe B. V.

Applicant before: Brocades drug companies

COR Change of bibliographic data

Free format text: CORRECT: APPLICANT; FROM: BROCADES PHARMACEUTICAL CO., LTD. TO: YAMAMOUCHI EURPE B. V.

C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C56 Change in the name or address of the patentee

Owner name: ANSTEIN PHARMACY EUROPE CO., LTD.

Free format text: FORMER NAME OR ADDRESS: YAMANOUCHI EUROPE LTD.

CP01 Change in the name or title of a patent holder

Address after: Holland Leiderdorp

Patentee after: Yamanouchi Europ BV

Address before: Holland Leiderdorp

Patentee before: Gist-brocades n.v.

C17 Cessation of patent right
CX01 Expiry of patent term